Wiest, Katharina

Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial

Hser, Y., Saxon, A. J., Huang, D., Hasson, A., Thomas, C., Hillhouse, M., Jacobs, P., Teruya, C., McLaughlin, P., Wiest, K., et al. (2014) · Addiction

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 455

Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Haight, B. R., Learned, S. M., Laffont, C. M., Fudala, P. J., Zhao, Y., Garofalo, A. S., Greenwald, M. K., Nadipelli, V. R., Ling, W., Heidbreder, C., et al. (2019) · The Lancet

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 285

Bupropion and naltrexone in methamphetamine use disorder

Trivedi, M. H., Walker, R., Ling, W., dela Cruz, A., Sharma, G., Carmody, T., Ghitza, U. E., Wahle, A., Kim, M., Shores-Wilson, K., et al. (2021) · New England Journal of Medicine

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 281

A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.

Gray, K. M., Sonne, S. C., McClure, E. A., Ghitza, U. E., Matthews, A. G., McRae-Clark, A. L., Carroll, K. M., Potter, J. S., Wiest, K., Mooney, L. J., et al. (2017) · Drug and Alcohol Dependence

Substance Abuse Treatment and OutcomesCannabis and Cannabinoid Research

Cited by 157

A preliminary study examining nutritional risk factors, body mass index, and treatment retention in opioid-dependent patients

Richardson, R. A., & Wiest, K. (2015) · The Journal of Behavioral Health Services & Research

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 14